ISTODAX FOR INJECTION (ROMIDEPSIN) Trademark

Trademark Overview

On Monday, February 8, 2010, a trademark application was filed for ISTODAX FOR INJECTION (ROMIDEPSIN) with the United States Patent and Trademark Office. The USPTO has given the ISTODAX FOR INJECTION (ROMIDEPSIN) trademark a serial number of 77930568. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, December 26, 2019. This trademark is owned by Astellas Pharma Inc.. The ISTODAX FOR INJECTION (ROMIDEPSIN) trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations as an anti-cancer drug for human uses
istodax for injection (romidepsin)

General Information

Serial Number77930568
Word MarkISTODAX FOR INJECTION (ROMIDEPSIN)
Filing DateMonday, February 8, 2010
Status800 - REGISTERED AND RENEWED
Status DateThursday, December 26, 2019
Registration Number3874930
Registration DateTuesday, November 9, 2010
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 6, 2010

Trademark Statements

Description of MarkThe mark consists of "ISTODAX" with a blue arc to the left of the blue "I" with the dot of the "I" in green; the remainder of the letters, "STODAX" in blue including the words (romidepsin) in parenthesis for injection in blue underneath "ISTODAX" .
Goods and Servicespharmaceutical preparations as an anti-cancer drug for human uses
Indication of Colors claimedThe color(s) blue and green is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"ROMIDEPSIN" AND "FOR INJECTION"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 17, 2010
Primary Code005
First Use Anywhere DateMonday, March 1, 2010
First Use In Commerce DateMonday, March 1, 2010

Trademark Owner History

Party NameCELGENE CORPORATION
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP
Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP
Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP

Trademark Events

Event DateEvent Description
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 26, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, December 26, 2019REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, December 26, 2019REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, December 26, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 11, 2019TEAS SECTION 8 & 9 RECEIVED
Saturday, November 9, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, January 14, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, January 14, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, January 14, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 9, 2015TEAS SECTION 8 & 15 RECEIVED
Monday, November 9, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 9, 2010REGISTERED-PRINCIPAL REGISTER
Wednesday, October 6, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 5, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, October 5, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 28, 2010STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 31, 2010USE AMENDMENT FILED
Tuesday, September 28, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 31, 2010TEAS STATEMENT OF USE RECEIVED
Tuesday, August 31, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 6, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 6, 2010PUBLISHED FOR OPPOSITION
Wednesday, June 2, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 2, 2010ASSIGNED TO LIE
Wednesday, May 19, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 19, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 18, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 18, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 17, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 17, 2010NON-FINAL ACTION E-MAILED
Monday, May 17, 2010NON-FINAL ACTION WRITTEN
Monday, May 10, 2010ASSIGNED TO EXAMINER
Thursday, February 18, 2010NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, February 17, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 11, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

romidepsin injection istodax human uses drug cancer preparations anti pharmaceutical